BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 7855658)

  • 21. The effectiveness of nicotine-patch therapy for smoking cessation in patients with schizophrenia.
    Chou KR; Chen R; Lee JF; Ku CH; Lu RB
    Int J Nurs Stud; 2004 Mar; 41(3):321-30. PubMed ID: 14967189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treating smokers before the quit date: can nicotine patches and denicotinized cigarettes reduce cravings?
    Rezaishiraz H; Hyland A; Mahoney MC; O'Connor RJ; Cummings KM
    Nicotine Tob Res; 2007 Nov; 9(11):1139-46. PubMed ID: 17978987
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of exercise and nicotine replacement therapy on smoking rates in women.
    Prapavessis H; Cameron L; Baldi JC; Robinson S; Borrie K; Harper T; Grove JR
    Addict Behav; 2007 Jul; 32(7):1416-32. PubMed ID: 17097814
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nicotine skin patch treatment increases abstinence, decreases withdrawal symptoms, and attenuates rewarding effects of smoking.
    Levin ED; Westman EC; Stein RM; Carnahan E; Sanchez M; Herman S; Behm FM; Rose JE
    J Clin Psychopharmacol; 1994 Feb; 14(1):41-9. PubMed ID: 8151002
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nicotine patch therapy prior to quitting smoking: a meta-analysis.
    Shiffman S; Ferguson SG
    Addiction; 2008 Apr; 103(4):557-63. PubMed ID: 18339101
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nicotine replacement therapy for patients with coronary artery disease. Working Group for the Study of Transdermal Nicotine in Patients with Coronary artery disease.
    Arch Intern Med; 1994 May; 154(9):989-95. PubMed ID: 8179456
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The use of nicotine patches with minimal intervention.
    Jolicoeur DG; Ahluwalia JS; Richter KP; Mosier M; Harris KJ; Gibson C; Moranetz CA
    Prev Med; 2000 Jun; 30(6):504-12. PubMed ID: 10901493
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Precessation treatment with nicotine patch significantly increases abstinence rates relative to conventional treatment.
    Rose JE; Herskovic JE; Behm FM; Westman EC
    Nicotine Tob Res; 2009 Sep; 11(9):1067-75. PubMed ID: 19567826
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transdermal nicotine patch enhances type I collagen synthesis in abstinent smokers.
    Sørensen LT; Jorgensen LN; Zillmer R; Vange J; Hemmingsen U; Gottrup F
    Wound Repair Regen; 2006; 14(3):247-51. PubMed ID: 16808802
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomized controlled trial of a web-based computer-tailored smoking cessation program as a supplement to nicotine patch therapy.
    Strecher VJ; Shiffman S; West R
    Addiction; 2005 May; 100(5):682-8. PubMed ID: 15847626
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The cost-effectiveness of the nicotine transdermal patch for smoking cessation.
    Wasley MA; McNagny SE; Phillips VL; Ahluwalia JS
    Prev Med; 1997; 26(2):264-70. PubMed ID: 9085397
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The safety, tolerability and efficacy of transdermal nicotine (Nicotinell TTS) in initially hospitalised patients.
    Martin PD; Robinson GM
    N Z Med J; 1995 Jan; 108(992):6-8. PubMed ID: 7862363
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of transdermal nicotine patches for nicotine replacement and smoking cessation.
    Holdcroft C
    Nurse Pract; 1992 Jul; 17(7):46-8. PubMed ID: 1495597
    [No Abstract]   [Full Text] [Related]  

  • 34. The nicotine transdermal patch: use in the dental office tobacco cessation program.
    Stafne EE
    Northwest Dent; 1994; 73(3):19-22. PubMed ID: 7816587
    [No Abstract]   [Full Text] [Related]  

  • 35. Transdermal nicotine patch for smoking cessation.
    Glover ED
    N Engl J Med; 1992 Jan; 326(5):344; author reply 345. PubMed ID: 1728741
    [No Abstract]   [Full Text] [Related]  

  • 36. Transdermal nicotine patch for smoking cessation.
    Varma JR
    N Engl J Med; 1992 Jan; 326(5):344; author reply 345. PubMed ID: 1728742
    [No Abstract]   [Full Text] [Related]  

  • 37. [Factors affecting the success or failure of smoking cessation using nicotine patches].
    Kawai H; Shibayama T; Tada A; Kawahara S; Soda R; Takahashi K
    Nihon Kokyuki Gakkai Zasshi; 2005 Mar; 43(3):144-9. PubMed ID: 15801282
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lack of efficacy of transdermal nicotine in smoking cessation.
    Joseph AM; Antonuccio DO
    N Engl J Med; 1999 Oct; 341(15):1157-8. PubMed ID: 10515763
    [No Abstract]   [Full Text] [Related]  

  • 39. Nicotine patch use in pregnant smokers: smoking abstinence and delivery outcomes.
    Schroeder DR; Ogburn PL; Hurt RD; Croghan IT; Ramin KD; Offord KP; Moyer TP
    J Matern Fetal Neonatal Med; 2002 Feb; 11(2):100-7. PubMed ID: 12375538
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of transdermal nicotine in a state-level prescription plan for the elderly. A first look at 'real-world' patch users.
    Orleans CT; Resch N; Noll E; Keintz MK; Rimer BK; Brown TV; Snedden TM
    JAMA; 1994 Feb; 271(8):601-7. PubMed ID: 8301792
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.